Table 3.
Univariate and multivariate logistic regression analysis to determine the effect of baseline characteristics and biomarkers on mortality and MV duration.
Variables | Univariate | Multivariate | ||
---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Mortality (yes vs. no) | ||||
Age | 0.957 (0.909–1.007) | 0.090 | 1.145 (1.007–1.303) | 0.039* |
Gender (female vs. male) | 0.787 (0.4–1.546) | 0.487 | – | – |
Comorbidity (yes vs. no) | 6.613 (1.512–28.918) | 0.012* | 3.821 (1.302–11.213) | 0.015* |
APACHE IV | 1.463 (1.253–1.708) | < 0.001* | – | – |
SOFA | 2.545 (1.813–3.572) | < 0.001* | 2.674 (1.271–5.624) | 0.01* |
Multiple organ failure (yes vs. no) | 7.000 (3.289–14.9) | < 0.001* | 4.179 (1.069–8.312) | < 0.001* |
Blood culture (yes vs. no) | 0.920 (0.461–1.836) | 0.814 | – | – |
ICU length of stay | 1.280 (1.135–1.443) | < 0.001* | 1.634 (1.135–4.243) | 0.002* |
Duration of MV | 1.733(1.426–2.106) | < 0.001* | 1.928 (1.105–3.363) | 0.021* |
Duration of using vasopressor | 4.538 (2.483–8.295) | < 0.001* | 3.753 (2.446–5.759) | < 0.001* |
RRT (yes vs. no) | 0.376 (0.173–0.816) | 0.013* | – | – |
Lactate/Albumin | 1.04 × 1018 (5.85 × 1012–84 × 1023) | < 0.001* | 7.57 × 1018 (11,049.220–5.19 × 1023) | 0.003* |
Lactate baseline | 0.946 (0.413–2.166) | 0.896 | – | – |
Lactate at 6 h | 3.468 (1.312–9.168) | 0.012* | 4.459 (0.158–125.51) | 0.381 |
Lactate at 12 h | 6.375 (4.467–8.963) | < 0.001* | 2.786 (0.077–10.678) | 0.576 |
Lactate at 24 h | 9.628 (2.767–10.763) | < 0.001* | 12.621 (4.833–14.944) | < 0.001* |
Clearance lactate at 6 h | 0.879 (0.82–0.942) | < 0.001* | 0.972 (0.858–1.102) | 0.66 |
Clearance lactate at 12 h | 0.857 (0.812–0.905) | < 0.001* | 0.964 (0.834–1.114) | 0.619 |
Clearance lactate at 24 h | 0.731 (0.655–0.815) | < 0.001* | 0.721 (0.608–0.854) | < 0.001* |
MV duration (≥ 6 days vs. < 6 days) | ||||
Age | 0.976 (0.921–1.033) | 0.395 | – | – |
Gender (female vs. male) | 0.618 (0.302–1.264) | 0.187 | – | – |
Comorbidity (yes vs. no) | 7.856 (0.995–10.122) | 0.998 | – | – |
APACHE IV | 1.335 (1.158–1.538) | < 0.001* | 0.977 (0.533–1.79) | 0.940 |
SOFA | 1.883 (1.377–2.575) | < 0.001* | 1.255 (1.361–4.367) | 0.021* |
Multiple organ failure (yes vs. no) | 11.2 (3.742–33.522) | < 0.001* | 0.529 (0.089–3.126) | 0.482 |
Blood culture (yes vs. no) | 1.546 (0.757–3.161) | 0.232 | – | – |
ICU length of stay | 4.005 (2.431–6.6) | < 0.001* | 4.547 (2.282–9.061) | < 0.001* |
RRT (yes vs. no) | 5.831 (1.682–20.214) | 0.005* | 0.371 (0.025–5.511) | 0.471 |
Duration of using vasopressor | 4.118 (2.478–6.845) | < 0.001* | 2.522 (1.203–5.289) | 0.014* |
Lactate/Albumin | 1.41 × 1013 (22,546,848.8–8.90073 × 1018) | < 0.001* | 6.03 × 1013 (1.918 × 1016–10.89 × 1016) | 0.003* |
Lactate baseline | 1.084 (0.459–2.561) | 0.854 | 0.835 (0.118–5.894) | 0.857 |
Lactate at 6 h | 2.018 (0.805–5.056) | 0.134 | 0.248 (0.023–2.676) | 0.251 |
Lactate at 12 h | 4.209 (1.718–10.316) | 0.002 | 0.269 (0.019–3.873) | 0.335 |
Lactate at 24 h | 10.10 (3.533–28.869) | < 0.001* | 18.83 (1.416–25.406) | 0.026* |
Clearance lactate at 6 h | 0.949 (0.897–1.004) | 0.070 | 1.074 (0.978–1.179) | 0.136 |
Clearance lactate at 12 h | 0.926 (0.885–0.968) | 0.001* | 1.041 (0.94–1.153) | 0.441 |
Clearance lactate at 24 h | 0.911 (0.875–0.948) | < 0.001* | 0.891 (0.804–0.988) | 0.029* |
OR odds ratio, CI confidence interval.
*P < 0.05 considered as significant.